Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

379 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy.
Di Biase L, Auricchio A, Sorgente A, Civello K, Klersy C, Faletra F, Riedlbauchova L, Patel D, Arruda M, Schweikert RA, Martin DO, Saliba WI, Moccetti T, Wilkoff BL, Natale A. Di Biase L, et al. Among authors: moccetti t. Eur Heart J. 2008 Oct;29(20):2497-505. doi: 10.1093/eurheartj/ehn221. Epub 2008 May 30. Eur Heart J. 2008. PMID: 18515806
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation.
Di Biase L, Auricchio A, Mohanty P, Bai R, Kautzner J, Pieragnoli P, Regoli F, Sorgente A, Spinucci G, Ricciardi G, Michelucci A, Perrotta L, Faletra F, Mlcochová H, Sedlacek K, Canby R, Sanchez JE, Horton R, Burkhardt JD, Moccetti T, Padeletti L, Natale A. Di Biase L, et al. Among authors: moccetti t. Europace. 2011 Jun;13(6):829-38. doi: 10.1093/europace/eur047. Epub 2011 Apr 12. Europace. 2011. PMID: 21486916
High recurrence of device-related adverse events following transvenous lead extraction procedure in patients with cardiac resynchronization devices.
Regoli F, Bongiorni MG, Rordorf R, Santamaria M, Klersy C, Segreti L, De Regibus V, Moccetti T, Conte G, Caputo ML, Auricchio A. Regoli F, et al. Among authors: moccetti t. Eur J Heart Fail. 2016 Oct;18(10):1270-1277. doi: 10.1002/ejhf.558. Epub 2016 May 12. Eur J Heart Fail. 2016. PMID: 27170594 Free article.
Comparison of eight echocardiographic methods for determining the prevalence of mechanical dyssynchrony and site of latest mechanical contraction in patients scheduled for cardiac resynchronization therapy.
Faletra FF, Conca C, Klersy C, Klimusina J, Regoli F, Mantovani A, Pasotti E, Pedrazzini GB, De Castro S, Moccetti T, Auricchio A. Faletra FF, et al. Among authors: moccetti t. Am J Cardiol. 2009 Jun 15;103(12):1746-52. doi: 10.1016/j.amjcard.2009.02.043. Epub 2009 May 4. Am J Cardiol. 2009. PMID: 19539087
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
Bartunek J, Terzic A, Davison BA, Filippatos GS, Radovanovic S, Beleslin B, Merkely B, Musialek P, Wojakowski W, Andreka P, Horvath IG, Katz A, Dolatabadi D, El Nakadi B, Arandjelovic A, Edes I, Seferovic PM, Obradovic S, Vanderheyden M, Jagic N, Petrov I, Atar S, Halabi M, Gelev VL, Shochat MK, Kasprzak JD, Sanz-Ruiz R, Heyndrickx GR, Nyolczas N, Legrand V, Guédès A, Heyse A, Moccetti T, Fernandez-Aviles F, Jimenez-Quevedo P, Bayes-Genis A, Hernandez-Garcia JM, Ribichini F, Gruchala M, Waldman SA, Teerlink JR, Gersh BJ, Povsic TJ, Henry TD, Metra M, Hajjar RJ, Tendera M, Behfar A, Alexandre B, Seron A, Stough WG, Sherman W, Cotter G, Wijns W; CHART Program. Bartunek J, et al. Among authors: moccetti t. Eur Heart J. 2017 Mar 1;38(9):648-660. doi: 10.1093/eurheartj/ehw543. Eur Heart J. 2017. PMID: 28025189 Free PMC article. Clinical Trial.
379 results